Twins place Scott Baker on disabled list, let Kevin Slowey out of doghouse

5 Comments

Kevin Slowey has been in the Twins’ doghouse all season because he didn’t take well to becoming a reliever when demoted from the rotation during spring training, but after spending several months in the minors he’s back in Minnesota to replace the injured Scott Baker.

As expected, Baker was placed on the disabled list with ongoing elbow problems. Initially the Twins indicated that Anthony Swarzak would get the nod if a rotation replacement was needed, but instead they called up Slowey. His first start will come Sunday against the Indians.

I’ve criticized the Twins’ handling of Slowey, from choosing Nick Blackburn and Brian Duensing over him for rotation spots to tearing him down through the media when he reacted poorly to the prospect of becoming a reliever after four successful seasons as a starter. With that said, it’s good to see them finally giving him another chance. For whatever faults Slowey has and however much blame he deserves for the negative situation, he’s a 27-year-old with a 4.42 ERA as a starter and the Twins can use the help.

Slowey was one of the Twins’ five best starters back in March and he’s one of the Twins’ five best starters now. Of course, if he pitches well in place of Baker the Twins would surely listen to trade offers on Slowey.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.